ENTRY       D12190                      Drug
NAME        Cadonilimab (USAN/INN)
FORMULA     C8772H13504N2384O2768S62
EXACT_MASS  198513.1897
MOL_WEIGHT  198635.4242
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFAFS SYDMSWVRQA PGKGLDWVAT ISGGGRYTYY
            PDSVKGRFTI SRDNSKNNLY LQMNSLRAED TALYYCANRY GEAWFAYWGQ GTLVTVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPEAAGAPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGKGG GGSGGGGSGG GGSGGGGSQV QLVESGAEVK
            KPGASVKVSC KASGYSFTGY TMNWVRQAPG QCLEWIGLIN PYNNITNYAQ KFQGRVTFTV
             DTSISTAYME LSRLRSDDTG VYFCARLDYR SYWGQGTLVT VSAGGGGSGG
            GGSGGGGSGG GGSQAVVTQE PSLTVSPGGT VTLTCGSSTG AVTTSNFPNW VQQKPGQAPR
            SLIGGTNNKA SWTPARFSGS LLGGKAALTI SGAQPEDEAE YYCALWYSNH WVFGCGTKLT
            VLR
            (Light chain)
            DIQMTQSPSS MSASVGDRVT FTCRASQDIN TYLSWFQQKP GKSPKTLIYR ANRLVSGVPS
            RFSGSGSGQD YTLTISSLQP EDMATYYCLQ YDEFPLTFGA GTKLELKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide birde: H22-H96, H145-H201, H221-L214, H227-H'227, H230-H'230, H262-H322, H368-H426, H490-H564, H512-H705, H625-H693, H'22-H'96, H'145-H'201, H'221-L'214, H'262-H'322, H'368-H'426, H'490-H'564, H'512-H'705, H'625-H'693, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Immune checkpoint inhibitor
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
            CTLA4 (CD152) [HSA:1493] [KO:K06538]
  PATHWAY   hsa04514(1493+5133)  Cell adhesion molecules
            hsa04660(1493+5133)  T cell receptor signaling pathway
            hsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D12190  Cadonilimab
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                CTLA4 (CD152)
                 D12190  Cadonilimab (USAN/INN)
                PDCD1 (PD1, CD279)
                 D12190  Cadonilimab (USAN/INN)
DBLINKS     CAS: 2394841-59-7
///
